Age at quitting smoking as a predictor of risk of cardiovascular disease incidence independent of smoking status, time since quitting and pack-years

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Mannan, Haider R ^a   Stevenson, Christopher E ^a   Peeters, Anna ^a   Walls, Helen L ^a   McNeil, John J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79851507906     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-39     Document Type: Article

References (29)

1. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. JM Lightwood SA Glantz, Circulation 1997 96 4 1089 96 9286934 (Pubitemid 27344208)
2. The Relationship of Smoking Cessation to Coronary Heart Disease and Lung Cancer in the Multiple Risk Factor Intervention Trial (MRFIT). JK Ockene LH Kuller K Svendsen M Meilahn, AJPH 1990 80 8 10.2105/AJPH.80.8.954
3. Cigarette Smoking, Cardiovascular Disease, and Stroke: A Statement for Healthcare Professionals From the American Heart Association. IS Ockene NH Miller, Circulation 1997 96 3243 3247 9386200 (Pubitemid 27500133)
4. Smoking cessation and the risk of stroke in middle-aged men. SG Wannamethee AG Shaper PH Whincup M Walker, JAMA 1995 274 155 160 10.1001/jama.274.2.155 7596004
5. Changes in weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. U Tamura T Tanaka T Okamura T Kadowaki H Yamato H Tanaka M Nakamura A Okayama H Ueshima Z Yamagata, Journal of Atherosclerosis & Thrombosis 2010 17 1 12 20
6. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. KK Teo S Ounpuu S Hawken MR Pandey V Valentin D Hunt R Diaz W Rashed R Freeman L Jiang X Zhang S Yusuf INTERHEART Study Investigators, Lancet 2006 368 9536 647 58 10.1016/S0140-6736(06)69249-0 16920470 (Pubitemid 44223693)
7. The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: pooled analysis of three large-scale cohort. K Honjo H Iso S Tsugane A Tamakoshi H Satoh K Tajima T Suzuki T Sobue, Tobacco Control 2010 19 50e57 10.1136/tc.2009.029751
8. Framingham risk prediction equations for CVD incidence using detailed measures for smoking. H Mannan C Stevenson A Peeters H Walls J McNeil, Heart International 2010 5 2 49 57 10.4081/hi.2010.e11
9. Mortality in relation to smoking: 50 years' observations on male British doctors. R Doll R Peto J Boreham I Sutherland, BMJ 2004 328 1519 (26 June) AE (published 22 June 2004) 10.1136/bmj.38142.554479.AE 15213107
10. The Effect of Smoking on Years of Healthy Life (YHL) Lost among Middle-Aged and Older Americans. T Ostbye DH Taylor Jr, Health Services Research 2004 39 531 551 10.1111/j.1475-6773.2004.00243.x 15149477 (Pubitemid 38685567)
11. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. D Wood R Wray N Poulter,, et al. Heart 2005 91 Suppl 5 & 221 v52 16365341
12. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. S D'Agostino S Grundy LM Sullivan P Wilson for the CHD Risk Prediction Group, JAMA 2001 286 180 187 11448281 (Pubitemid 32640849)
13. Risk scoring in the assessment of cardiovascular risk. A Beswick P Brindle, Curr Opin Lipidol 2006 17 375 386 1999; 159: 1197-1204 10.1097/01.mol.0000236362.56216.44 16832160 (Pubitemid 44079474)
14. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. J Liu Y Hong RB D'Agostino Sr Z Wu W Wang J Sun PW Wilson WB Kannel D Zhao, JAMA 2004 291 2591 2599 10.1001/jama.291.21.2591 15173150 (Pubitemid 38702777)
15. General Cardiovascular Risk Profile for Use in Primary Care. RB D'Agostino Sr RS Vasan MJ Pencina PA Wolf M Cobain JA Massaro WB Kannel, Circulation 2008 117 743 753 18212285 (Pubitemid 351640675)
16. Regression models and life tables. DR Cox, J Royal Stat Soc 1972 34 series B 187 220
17. Applied Survival Analysis: Regression Modeling of Time to Event Data. DW Hosmer Jr S Lemeshow
18. Bias and Efficiency Loss Due to Categorizing an Explanatory Variable, Journal of Multivariate Analysis. JMG Taylor M Yu, 2002 83 248 263
19. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. FE Harrell Jr KL Lee DB Mark, Stat Med 1996 15 361 387 10.1002/(SICI)1097-0258(19960229)15: 4<361::AID-SIM168>3.0.CO;2-4 8668867 (Pubitemid 26072233)
20. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Handbook of Statistics. R D'Agostino BH Nam, Amsterdam, The Netherlands: Elsevier 2004 1 25
21. Inference on correlated discrimination measures in survival analysis: a nonparametric approach. L Antolini BH Nam RB Agostino, Commun Stat Theory Methods 2004 33 2117 2135 10.1081/STA-200026579
22. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. MS Pepe H Janes G Longton W Leisenring P Newcomb, American Journal of Epidemiology 2004 159 882 890 10.1093/aje/kwh101 15105181 (Pubitemid 38657490)
23. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. P Greenland PG O'Malley, Archives of Internal Medicine 2005 165 21 2454 2456 10.1001/archinte.165.21.2454 16314539 (Pubitemid 41720004)
24. The limitations of risk factors as prognostic tools. JH Ware, New England Journal of Medicine 2006 355 2615 2617 10.1056/NEJMp068249 17182986 (Pubitemid 44969120)
25. Assessing the value of risk predictions by using risk stratification tables. H Janes MS Pepe W Gu, Annals of Internal Medicine 2008 149 10 751 760 19017593
26. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: Towards a decision analytic framework. AJ Vickers AM Cronin, Seminars in Oncology 2010 37 1 31 38 10.1053/j.seminoncol. 2009.12.004 20172362
27. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. MJ Pencina RB D'Agostino Sr RB D'Agostino Jr RS Vasan, Stat Med 2008 27 157 172 10.1002/sim.2929 17569110 (Pubitemid 351193639)
28. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. MJ Pencina RB D'Agostino, Stat Med 2004 23 2109 2123 10.1002/sim.1802 15211606 (Pubitemid 38968032)
29. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702